Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2023-06-01 00:00:00 ET · period of report 2023-05-31 · accession 0001104659-23-066844 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-01 | 2023-05-31 | NVCT | BENTSUR RON | COB, CEO, Dir, 10% | P - Purchase | $17.28 | +330 | 3.23M | +0.0% | +$5,702 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-31 | P | A | 330 | $17.28 | 3,229,179 | D | — | — | (F1) Includes 426,759 shares of restricted stock. |